Реинфузия крови в хирургии. Современное состояние проблемы

А.Ю. Лубнин, В.В. Громова

ФГАУ «Национальный медицинский исследовательский центр нейрохирургии им. акад. Н.Н. Бурденко» Минздрава Российской Федерации, Москва, Россия

Для корреспонденции: Лубнин Андрей Юрьевич — д-р мед. наук, профессор, руководитель отдела анестезиологии, реанимации и интенсивной терапии ФГАУ «НМИЦ нейрохирургии им. акад. Н.Н. Бурденко» МЗ РФ, Москва; е-mail: lubnin@nsi.ru

Для цитирования: Лубнин А.Ю., Громова В.В. Реинфузия крови в хирургии. Современное состояние проблемы. Вестник интенсивной терапии имени А.И. Салтанова. 2019;4:58–67.

DOI: 10.21320/1818-474X-2019-4-58-67


Реферат

В работе на основании данных литературы и собственного опыта анализируется современное состояние проблемы реинфузии крови в хирургии. Рассмотрены технические решения, методические подходы, аппаратура для проведения реинфузии крови у хирургических больных. Также рассмотрены такие аспекты проблемы, как показания, противопоказания и особенности применения методики в различных областях хирургии.

Ключевые слова: реинфузия крови в хирургии, технические решения, показания и противопоказания, возможные осложнения

Поступила: 06.03.2019

Принята к печати: 05.11.2019


Литература

  1. Громова В.В., Лубнин А.Ю. История развития реинфузии крови в хирургии. Вестн. инт. терапии. 2008; 3: 81–87. [Gromova V.V., Lubnin A.Yu. History of development of blood reinfusion in surgery. Int. Ther. Gerald. 2008; 3: 81–87. (In Russ)]
  2. Громова В., Лубнин А. История развития реинфузии крови в хирургии. Ч. 2. Вестн. инт. терапии. 2008; 4: 65–72. [Gromova V.V., Lubnin A.Yu. History of development of blood reinfusion in surgery. Int. Ther. Gerald. 2008; 4: 65–72. (In Russ)]
  3. Громова В., Лубнин А. История развития реинфузии крови в хирургии. Ч. 3. Вестн. инт. терапии. 2009; 1: 62–68. [Gromova V.V., Lubnin A.Yu. History of development of blood reinfusion in surgery. Int. Ther. Gerald. 2009; 1: 62–68. (In Russ)]
  4. Kaspar S.-M., Neis K. The history of autologous blood transfusion. In: Hempelman G., et al. (Eds.). Autologous haemotherapy. Bierman. 1994: 1–9.
  5. Лубнин А., Громова В., Ханзен Э. Реинфузия крови в хирургии. Тверь: Триада, 2013. [Lubnin A.Yu., Gromova V.V., Hansen E. Blood reinfusion in surgery. Tver: Triada, 2013. (In Russ)]
  6. Ханзен Э. Почему нельзя переливать больному необработанную раневую кровь. В кн.: Лубнин А.Ю., Громова В.В., Ханзен Э. Реинфузия крови в хирургии. Тверь: Триада, 2013: 212–229.[Hansen E. Why it is impossible reinfused to the patient nonprocessed blood. In: Lubnin A.Yu., Gromova V.V., Hansen E. Blood reinfusion in surgery. Tver: Triada, 2013: 212–229. (In Russ)]
  7. Konig G., Waters J.H. Washing and filtering of cell — salvaged blood — does it make autotransfusijn safer? TATM. 2012. DOI: 10.1111/j.1778-428X.2012.01155.x
  8. Sikorsky R.A., Rizkalla N.A., Young W.W., Frank S.M. Autologous blood salvage in the era of patient blood management. VoxSang. 2017. DOI: 10.1111/vox.12527
  9. Burman J.F., Westlake A.S., Davidson S.J., et al. Study of five cell salvage machines in coronary artery surgery. Transfus. Med. 2002; 12: 173–179.
  10. Yarham G., Clements A., Oliver M., et al. Evaluating the “next generation” of cell salvage — will it make difference? Perfusion. 2011; 26: 263–270. DOI: 10.1177/02676591111399951
  11. Alberts M., Groom R.C., Walczak R.Jr., et al. In vitro evaluation of the Fresenius Kabi CFTSmart autotransfusion system. J. Extra Corpor. Technol. 2017; 49: 107–111.
  12. Lindau S., Kohlhaas M., Nosch M., et al. Cell salvage using the continuous autotransfusion device CATSmart — an observational bicenter technical evaluation. BMC Anesthesiol. 2018; 18: 189. DOI: 10.1186/s12871-018-0651-0
  13. Громова В.В., Лубнин А.Ю. Анализ современных аппаратов для реинфузии крови. Анест. и реан. 2009; 5: 71–76. [Gromova V.V., Lubnin A.Yu. An analysis of modern devices for blood reinfusion. Anesth. Reanim. 2009; 5: 71–76. (In Russ)]
  14. Громова В.В., Лубнин А.Ю. Современное техническое обеспечение реинфузии крови. В кн.: Лубнин А.Ю., Громова В.В., Ханзен Э. Реинфузия крови в хирургии. Тверь: Триада, 2013: 175–211.[Gromova V.V., Lubnin A.Yu. Modern technical equipment for blood reinfusion. In: Lubnin A.Yu., Gromova V.V., Hansen E. Blood reinfusion in surgery. Tver: Triada, 2013: 175–211. (In Russ)]
  15. Громова В., Лубнин А., Мошкин А., Гаджиева О. Интраоперационная реинфузия эритроцитов в нейроанестезиологии. Анест. и реан. 2001; 2: 35–43. [Gromova V.V., Lubnin A.Yu., Moshkin A.V., et al. Intraoperative blood reinfusion in neuroanesthesiology. Anesth. Rean. 2001; 2: 35–43. (In Russ.)]
  16. Громова В., Лубнин А. Применение реинфузии крови в нейрохирургии. В кн.: Лубнин А.Ю., Громова В.В., Ханзен Э. Реинфузия крови в хирургии. Тверь: Триада, 2013: 264–305.[Gromova V.V., Lubnin A.Yu. Blood reinfusion in neuroanesthesiology. In: Lubnin A.Yu., Gromova V.V., Hansen E. Blood reinfusion in surgery. Tver: Triada, 2013: 264–305. (In Russ)]
  17. Лубнин А.Ю., Громова В.В. Проблема операционной кровопотери и применение современных кровесберегающих методик в нейроанестезиологии. Анест. и Реан. 2003; 3: 26–30. [Lubnin A.Yu., Gromova V.V. The problem of blood loss and utilization of modern blood saving technologies in neuroanesthesiology. Anesth. Rean. 2003; 3: 26–30. (In Russ)]
  18. AABB. Standards for perioperative autologous blood collection and administration. 7th edition. ISBN: 9781563959295. http: www.aabb.org/press/Pages/pr140325
  19. Gousher H., Wong C.A., Patel S.K., et al. Cell salvage in obstetrics. Anesth. Analg. 2015; 121: 465–468. DOI: 10.1213/ANE0000000000000786
  20. Milne M.E., Yozer M.H., Waters J.H. Red blood cell salvage during obstetric hemorrhage. Obstet. Gynecol. 2015: 125: 919–923.
  21. Ханзен Э. Реинфузия крови в онкохирургии. В кн.: Лубнин А.Ю., Громова В.В., Ханзен Э. Тверь: Триада, 2013: 398–423. [Hansen E. Blood reinfusion in oncologic surgery. In: Lubnin A.Yu., Gromova V.V., Hansen E. Blood reinfusion in surgery. Tver: Triada, 2013: 398–423. (In Russ)]
  22. Hansen E., Bechman V., Altmehhen J. Intraoperative blood salvage in oncologic surgery — Answers to current questions. Infus. Ther. Transf. Med. 2002; 29: 138–141.
  23. Hansen E., Wolf N., Knuechel R., et al. Tumor cells in blood shed from the surgical field. Arch. Surg. 1995; 130: 387–393.
  24. Hansen E. Cell salvage in the presence of malignancy. TATM. 2003; 5: 472–477.
  25. Valbonesi M., Bruni R., Giannini G., Florio G. Intraoperative blood salvage (IOBS) for tumor surgery. Int. J. Artif. Org. 1998; 21: 1–3.
  26. Kumar N., Zaw A.S., Kantharajanna S.B., et al. Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? Transfus. Med. 2017; Suppl. 5: 327–334. DOI: 10.1111/tme.12453
  27. Zaw A.S., Bangalore Kanthrajanna S., Kumar N. Is autologous salvaged blood a viable option for patient blood management in oncologic surgery? Transfus. Med. Rev. 2017; 31: 56–61. DOI: 10.1016/j.tmrv.2016.06.003
  28. Miller G.V., Ramsden C.W., Primrose J.N. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br. J. Surg. 1991; 78: 713–715.
  29. Connor J.P., Morris P.C., Alagoz T., et al. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancer of uterine cervix. Obstet. Gynecol. 1995; 86: 373–378.
  30. Klimberg J., Sirois R., Wajsman Z. Intraoperative autotransfusion in urologic oncology. Arch. Surg. 1986; 121: 1326–1329.
  31. Pisters L.L., Wajsman Z. Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology. 1992; 40: 211–215.
  32. Cataldi S., Bruder N., Dufor H., et al. Intraoperative autologous blood transfusion in intracranial surgery. Neurosurgery. 1997; 40: 765–772.
  33. Muller M., Kuhn D.F., Hinrichs B., et al. Ist die elimination von osteosarkomzellen durch “mashinielle autotransfusion” und leukozyten-depletionsfilter moglich? Anaesthesist. 1996; 45: 834–838.
  34. Kongsgaard U.E., Wang M.Y., Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesth. Scand. 1996; 40: 118–120.
  35. Perseghin P., Vigano M., Rocco G., et al. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer surgery. VoxSang. 1997; 72: 221–224.
  36. Wiesel M., Gudemann C., Staehlev G. Tumorzellseparation durch cell — saver und membranfilterpassage. Infusionstherapie. 1991; 18: 143–144.
  37. DeAndrade D., Waters J.H., Triulzi D.J., et al. Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage. Transfusion. 2016; 56: 2768–2772. DOI: 10.1111/trf.13791
  38. Froessler B., Weber I., Hodyl N.A., Saadat-Gilani K. Dynamic changes in clot formation determined using thromboelastometry after reinfusion of unwashed anticoagulated cell-salvaged whole blood in total hip arthroplasty. Blood Transfus. 2015; 13; 448–454. DOI: 10.2450/2015.0311-14
  39. Konig G., Yazer M.H., Waters J.H. The effect of salvaged blood on coagulation function as measured by thromboelastography. Transfusion. 2013; 53: 1235–1239. DOI: 10.1111/j.1537-2995.2012.03884.x
  40. Luque-Oliveros M. Haematological alterations in the cardiac patient after use of an autotransfusion system. Rev. Esp. Anestesiol. Reanim. 2018; 65: 74–80. DOI: 10.1016/j.redar.2017.09.003
  41. Keverline J.P., Sanders J.O. Hematuria associated with low-volume cell saver in pediatric orthopedics. J. Pediatr. Orthop. 1998; 18: 594–597.
  42. Minkara A.A., Lin A.Y., Vitale M.G., Roye D.P. Acute kidney injury secondary to cell saver in posterior spinal fusion. Spine Deform. 2017; 5: 430–434. DOI: 10.1016/j.jspd.2017.03.010
  43. You D., Peiro-Garcia A., Ferri-de-Barros F., Parsons D. Hemolysis following intraoperative cell salvage replacement in scoliosis patient with sickle cell trait: a case report. Spine. 2017; 42: E1332–E1333. DOI: 10.1097/BRS.0000000000002211
  44. Linden J.V., Kaplan H.S., Murphy M.T. Fatal air embolism due to perioperative blood recovery. Anesth. Analg. 1997; 84: 422–426.
  45. Bland L.A., Villarino M.E., Arduino M.J., et al. Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusion during cardiac operations. J. Thorac. Cardiovasc. Surg. 1992; 103: 582–588.
  46. Filtracco P., Michioletto S., Barbieri S., et al. Microbiologic contamination of intraoperative blood salvaged during liver transplantation. Transplant. Proceed. 2007; 39: 1889–1891.
  47. Kudo H., Fuita H., Hanada Y., et al. Cytological and bacteriological studies of intraoperative autologous blood in neurosurgery. Surg. Neurol. 2004; 62: 195–200.
  48. Duffu G., Neal K.R. Differences in post-operative infection rates between patients receiving autologous and allogenic blood transfusion: a meta-analysis of published randomized and nоn-randomized studies. Transfus. Med. 1996; 6: 325–328.
  49. Klasan A., Dworchak P., Heyse T.J., et al. Transfusions increase complications and infections after hip and knee arthroplasty: an analysis of 2760 cases. Technol. Health Care. 2018; 26: 825–832. DOI: 10.3233/THC-181324
  50. Perez-Ferrer A., Gredilla-Diaz E., de Vicente-Sanchez J., et al. Vancomycin added to the wash solution of the cell-saver. Effect on bacterial contamination. Rev. Esp. Anestesiol. Reanim. 2017; 64: 185–191. DOI: 10.1016/j.redar.2016.10.002
  51. Waters J., Tuohy M., Hobson D., et al. Bacterial reduction by cell-saver salvage washing and leukocyte depletion filtration. Anesthesiology. 2003; 99: 652–655.
  52. Parker L.M., Yazer M.H., Waters J.H. Metallosis identified via intraoperative cell salvage: a case report. A.A.Case Rep. 2017; 8: 67–69. DOI: 10.1213/XAA.0000000000000428
  53. Kim J.H., Bae J.Y., Lee S.I., et al. Blood clot formation in reinfusion bag with CATSmart: two case report. Int. J. Artif. Organs. 2019; 42: 668–672. DOI: 10.1177/0391398819855403
  54. Bomberg H., Volk T., Biedler A., Schneider S.O. Impact of intraoperative blood salvage on monocyte subsets alteration and intracellular tumor necrosis factor alfa production. J. Biomed. Res. A. 2018; 106: 815–821. DOI: 10.1002/jbm.a.36281
  55. Wang G., Bainbridge D., Pharm P., Cheng D. The efficacy of an intraoperative cell-saver during cardiac surgery: A meta-analysis of randomized trials. Anesth. Analg. 2009; 109: 320–323.
  56. Yuet C., Salmi L.R., Fergusson D., et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogenic blood transfusion in cardiac and orthopedic surgery. International study of perioperative transfusion (ISPOT) investigators. Anesth. Analg. 1999; 89: 861–869. DOI: 10.1097/00000539-199910000-00009
  57. Xie Y., Shen S., Zhang J., Wang J., Zheng J. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in hugh-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. Int. J. Med. Sci. 2015; 12: 322–328. DOI: 10.7150/ijms.11227
  58. Raphael C.E., Maor E., Panaich S.S., et al. The use of intraprocedural reinfusion during mitraclip implantation to reduce blood loss and transfusion requirements. J. Invasive Cardiol. 2018; 30: E1–E3.
  59. Fiocca L., Cereda A.F., Bernelli C., et al. Autologous blood reinfusion during iatrogenic acute hemorrhagic cardiac tamponade: safety and feasibility in a cohort of 30 patients. Catheter Cardiovasc. Interv. 2019; 93: E56–E62. DOI: 10.1002/ccd.27784
  60. Капырина М., Аржакова Н. Инфузионно-трансфузионная терапия и реинфузия крови при травматолого-ортопедических вмешательствах. В кн.: Лубнин А.Ю., Громова В.В., Ханзен Э. Реинфузия крови в хирургии. Тверь: Триада, 2013: 304–350.[Kapirina M.V., Arjakova N.I. Infusion-transfusion therapy and blood reinfusion during traumatologic and orthopedic surgery. In: Lubnin A.Yu., Gromova V.V., Hansen E. Blood reinfusion in surgery. Tver: Triada, 2013: 304–350. (In Russ)]
  61. Tevet A., Grisaru-Granovsky S., Samuelof A., Joscovich A. Peripartum use of cell salvage: a university practical audit and literature review. Arch. Gynecol. Obstet. 2012; 285: 281–284.
  62. Федорова Т.А., Рогачевский О.В. Реинфузия крови в акушерстве и гинекологии. В кн.: Лубнин А.Ю., Громова В.В., Ханзен Э. Реинфузия крови в хирургии. Тверь: Триада, 2013: 218–246.[Fedorova T.A., Rogachevsky O.V. Blood reinfusion in obstetrics and gynecology. In: Lubnin A.Yu., Gromova V.V., Hansen E. Blood reinfusion in surgery. Tver: Triada, 2013: 218–246. (In Russ)]
  63. Dharival S.K., Khan K.S., Allard S., et al. Does current evidence support the use of intraoperative cell salvage in reducing the need for blood transfusion in caesarean section. Curr. Opin. Obstet. Gynecol. 2014; 26: 425–430.
  64. Khan K.S., Moore P., Wilson M., et al. A randomized controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell salvage in obstetrics) trial. Health Technol. Assess. 2018; 22: 1–88.
  65. Lim G., Melnyk V., Facco F.L., et al. Cost — effectiveness analysis of intraoperative cell salvage for obstetric hemorrhage. Anesthesiology. 2018; 128: 128–134.
  66. Djurasovic M., McGraw K.E., Bratcher K., et al. Randomized trial of cell saver in 2- tj 3-level lumbar instrumented posterior fusions. J. Neurosurg. Spine. 2018; 29: 582–587. DOI: 10.3171/2018.4.SPINE18116
  67. Hasan M.S., Choe N.C., Chan C.Y.W., et al. Effect of intraoperative autologous transfusion techniques on perioperative hemoglobin level in idiopathic scoliosis patients undergoing posterior spinal fusion: a prospective randomized trial. J. Orthop. Surg. 2017; 25: 2309499017718951. DOI: 10.1177/2309499017718951
  68. Gum J.L., Carreon L.Y., Kelly M.P., et al. Cell saver for adult spinal deformity surgery reduced cost. Spine Deform. 2017; 5: 272–274. DOI: 10.1016/j.jspd.2017.01.005
  69. Liu J.M., Fu B.Q., Chen W.Z., et al. Cell salvage used in scoliosis surgery: Is it really effective? World Neurosurg. 2017; 101: 568–576. DOI: 10.1016/j.wneu.2017.02.057
  70. Stone N., Sardana V., Missiuna P. Indications and outcomes of cell saver in adolescent scoliosis correction surgery: A systematic review. Spine. 2017; 42: E363–E370. DOI: 10.1097/BRS.0000000000001780
  71. Nemani V.M., Kim H.J., Mina C.A., et al. Post-operative blood salvage and autotransfusion for adult spinal deformity: A randomized controlled trial. Spine. 2019. DOI: 10.1097/BRS.0000000000003176
  72. Elmalky M., Yasin N., Rodrigues-Pinto R., et al. The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. Spine J. 2017; 17: 977–982. DOI: 10.1016/j.spinee.2017.03.004
  73. Kumar N., Ravikumar N., Tan J.Y.H., et al. Current status of the use of salvaged blood in metastatic spine tumour surgery. Neurospine. 2018; 15: 206–215. DOI: 10.14245/ns.1836140.070
  74. Леменева Н.В., Сорокин В.С., Лубнин А.Ю. Кровесберегающие технологии в детской нейроанестезиологии. Анест. и реан. 2008; 2: 22–26. [Lemeneva N.V., Sorokin V.S., Lubnin A.Yu. Blood saving technologies in pediatric neuroanesthesiology. Anest. Rean. 2008; 2: 22–26. (In Russ.)]
  75. Samnaliev M., Tran C.M., Sloan S.R., et al. Economic evaluation of cell salvage in pediatric surgery. Pediatr. Anesth. 2013; 23: 1027–1034. DOI: 10.1111/pan.12233
  76. Pinto M.A., Chedid M.F., Sekine L., et al. Intraoperative cell salvage with autologous transfusion in liver transplantation. World J. Gastrointest. Surg. 2019; 11: 11–18. DOI: 10.4240/wjgs.v11.i1.11